JP2024528987A5 - - Google Patents

Info

Publication number
JP2024528987A5
JP2024528987A5 JP2024506669A JP2024506669A JP2024528987A5 JP 2024528987 A5 JP2024528987 A5 JP 2024528987A5 JP 2024506669 A JP2024506669 A JP 2024506669A JP 2024506669 A JP2024506669 A JP 2024506669A JP 2024528987 A5 JP2024528987 A5 JP 2024528987A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528987A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074496 external-priority patent/WO2023015225A1/en
Publication of JP2024528987A publication Critical patent/JP2024528987A/ja
Publication of JP2024528987A5 publication Critical patent/JP2024528987A5/ja
Pending legal-status Critical Current

Links

JP2024506669A 2021-08-04 2022-08-03 抗ｐｌａ２ｇ２ｄ構築物およびその使用 Pending JP2024528987A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163229437P 2021-08-04 2021-08-04
US63/229,437 2021-08-04
PCT/US2022/074496 WO2023015225A1 (en) 2021-08-04 2022-08-03 Anti-pla2g2d constructs and uses thereof

Publications (2)

Publication Number Publication Date
JP2024528987A JP2024528987A (ja) 2024-08-01
JP2024528987A5 true JP2024528987A5 (cg-RX-API-DMAC7.html) 2025-08-13

Family

ID=85128598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506669A Pending JP2024528987A (ja) 2021-08-04 2022-08-03 抗ｐｌａ２ｇ２ｄ構築物およびその使用

Country Status (6)

Country Link
US (1) US20240327540A1 (cg-RX-API-DMAC7.html)
EP (1) EP4380690A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024528987A (cg-RX-API-DMAC7.html)
CN (1) CN118139894A (cg-RX-API-DMAC7.html)
AU (1) AU2022323177A1 (cg-RX-API-DMAC7.html)
CA (1) CA3178008A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021155305A1 (en) * 2020-01-30 2021-08-05 Apeximmune Therapeutics Inc. Methods and compositions for treating cancer or viral infection with a pla2g2d antagonist

Similar Documents

Publication Publication Date Title
JP2023543031A5 (cg-RX-API-DMAC7.html)
JP2021508469A5 (cg-RX-API-DMAC7.html)
JP2022515318A5 (cg-RX-API-DMAC7.html)
JP2023529842A5 (cg-RX-API-DMAC7.html)
JP2023516004A5 (cg-RX-API-DMAC7.html)
JP2023536461A5 (cg-RX-API-DMAC7.html)
KR20180004277A (ko) Pdl-1 항체, 그 약학적 조성물 및 그 용도
JP2023539501A5 (cg-RX-API-DMAC7.html)
US20250034273A1 (en) Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof
JP2022533538A5 (cg-RX-API-DMAC7.html)
CN117946278A (zh) 多特异性抗体及其制备和使用方法
JP7679399B2 (ja) 抗ｆｌｔ３抗体及び組成物
JP2023549537A5 (cg-RX-API-DMAC7.html)
JP2020533004A5 (cg-RX-API-DMAC7.html)
JP2022553922A5 (cg-RX-API-DMAC7.html)
JP2022545741A5 (cg-RX-API-DMAC7.html)
JP2021525806A5 (cg-RX-API-DMAC7.html)
JP2022532991A5 (cg-RX-API-DMAC7.html)
JP2023516941A5 (cg-RX-API-DMAC7.html)
EP4506360A1 (en) Anti-pvrig antibody, pharmaceutical composition thereof and use thereof
JP2024054284A (ja) ガンの処置のための結合分子
JP2020513759A5 (cg-RX-API-DMAC7.html)
KR20240164815A (ko) 항-tigit/항-pvrig 이중특이적 항체, 이의 약제학적 조성물 및 이의 용도
JP2025511289A5 (cg-RX-API-DMAC7.html)
JP2025511288A5 (cg-RX-API-DMAC7.html)